advertisement

---

Hu L 21

Showing records 1 to 21 | Display all abstracts from Hu L

119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Yuan H
Biomarkers in medicine 2024; 18: 545-553

---

123696 Injectable hydrogels based on biopolymers for the treatment of ocular diseases
Yu C
International Journal of Biological Macromolecules 2024; 269: 132086

---

119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Li A
Biomarkers in medicine 2024; 18: 545-553

---

123696 Injectable hydrogels based on biopolymers for the treatment of ocular diseases
Xu J
International Journal of Biological Macromolecules 2024; 269: 132086

---

119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Chen L
Biomarkers in medicine 2024; 18: 545-553

---

123696 Injectable hydrogels based on biopolymers for the treatment of ocular diseases
Heidari G
International Journal of Biological Macromolecules 2024; 269: 132086

---

119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Wang Z
Biomarkers in medicine 2024; 18: 545-553

---

123696 Injectable hydrogels based on biopolymers for the treatment of ocular diseases
Jiang H; Shi Y
International Journal of Biological Macromolecules 2024; 269: 132086

---

119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Zhu X
Biomarkers in medicine 2024; 18: 545-553

---

123696 Injectable hydrogels based on biopolymers for the treatment of ocular diseases
Wu A
International Journal of Biological Macromolecules 2024; 269: 132086

---

119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Wang J
Biomarkers in medicine 2024; 18: 545-553

---

123696 Injectable hydrogels based on biopolymers for the treatment of ocular diseases
Makvandi P
International Journal of Biological Macromolecules 2024; 269: 132086

---

119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Xiu W
Biomarkers in medicine 2024; 18: 545-553

---

123696 Injectable hydrogels based on biopolymers for the treatment of ocular diseases
Neisiany RE
International Journal of Biological Macromolecules 2024; 269: 132086

---

119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Chen Y; Zhang G
Biomarkers in medicine 2024; 18: 545-553

---

123696 Injectable hydrogels based on biopolymers for the treatment of ocular diseases
Zare EN
International Journal of Biological Macromolecules 2024; 269: 132086

---

119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Liu D
Biomarkers in medicine 2024; 18: 545-553

---

123696 Injectable hydrogels based on biopolymers for the treatment of ocular diseases
Shao M
International Journal of Biological Macromolecules 2024; 269: 132086

---

119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Xiao X
Biomarkers in medicine 2024; 18: 545-553

---

123696 Injectable hydrogels based on biopolymers for the treatment of ocular diseases
Hu L
International Journal of Biological Macromolecules 2024; 269: 132086

---

119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Sun C; Lu F; Hu L; He C
Biomarkers in medicine 2024; 18: 545-553

---